Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Gene therapy].

B Zabel1

  • 1Universität-Kinderklinik, Mainz.

Monatsschrift Kinderheilkunde : Organ Der Deutschen Gesellschaft Fur Kinderheilkunde
|May 1, 1989
PubMed
Summary
This summary is machine-generated.

DNA technology offers new treatments for hereditary diseases through gene therapy. Current research focuses on somatic gene therapy, avoiding heritable germline modifications.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A NOVEL MUTATION ASSOCIATED WITH NEPHROLITIHASIS IN ELLIS-VAN CREVELD SYNDROME.

Genetic counseling (Geneva, Switzerland)·2015
Same author

Autosomal recessive mutations in the COL2A1 gene cause severe spondyloepiphyseal dysplasia.

Clinical genetics·2014
Same author

Schmid-type metaphyseal chondrodysplasia as the result of a collagen type X defect due to a novel COL10A1 nonsense mutation: A case report of a novel COL10A1 mutation.

Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association·2011
Same author

Novel and recurrent TRPV4 mutations and their association with distinct phenotypes within the TRPV4 dysplasia family.

Journal of medical genetics·2010
Same author

[Lung diseases - pulmonary hypertension].

Der Internist·2009
Same author

[Skeletal dysplasias. The network SKELNET].

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·2007
Same journal

[The COVID-19 pandemic-How did it affect the mental health of children?]

Monatsschrift Kinderheilkunde : Organ der Deutschen Gesellschaft fur Kinderheilkunde·2023
Same journal

[COVID-19 vaccination in children and adolescents].

Monatsschrift Kinderheilkunde : Organ der Deutschen Gesellschaft fur Kinderheilkunde·2023
Same journal

[Prevalence of post-COVID-19 in nonhospitalized adolescents and young adults].

Monatsschrift Kinderheilkunde : Organ der Deutschen Gesellschaft fur Kinderheilkunde·2023
Same journal

[Education and education deficits in day care centers and schools during the coronavirus pandemic].

Monatsschrift Kinderheilkunde : Organ der Deutschen Gesellschaft fur Kinderheilkunde·2023
Same journal

[Learning deficits in the COVID-19 pandemic].

Monatsschrift Kinderheilkunde : Organ der Deutschen Gesellschaft fur Kinderheilkunde·2023
Same journal

[Pediatrics up to date-Brief notes on research].

Monatsschrift Kinderheilkunde : Organ der Deutschen Gesellschaft fur Kinderheilkunde·2023
See all related articles

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Genetics

Context:

  • Hereditary diseases present significant challenges in treatment.
  • DNA technology provides novel therapeutic avenues.

Purpose:

  • To explore the potential of DNA technology in treating hereditary diseases.
  • To review the ethical considerations and current research focus in human gene therapy.

Summary:

  • DNA technology, including retrovirus-mediated gene transfer, enables the introduction of cloned human genes into cell genomes to correct genetic defects.
  • Ethical consensus discourages germline gene therapy due to heritable alterations.
  • Current research prioritizes somatic gene therapy, which targets non-reproductive cells.

Impact:

  • Somatic gene therapy offers a promising approach for treating genetic disorders.
  • Advances in DNA technology pave the way for targeted genetic interventions.